Statement Of Changes In Equity [Abstract]

Sopharma Trading AD - Filing #6022492

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
24,912,000.000 BGN
25,773,000.000 BGN
225,000.000 BGN
50,463,000.000 BGN
84,900,000.000 BGN
797,000.000 BGN
34,276,000.000 BGN
789,000.000 BGN
34,276,000.000 BGN
76,938,000.000 BGN
10,723,000.000 BGN
29,609,000.000 BGN
22,595,000.000 BGN
392,000.000 BGN
76,938,000.000 BGN
34,276,000.000 BGN
2,038,000.000 BGN
21,806,000.000 BGN
75,804,000.000 BGN
20,585,000.000 BGN
395,000.000 BGN
780,000.000 BGN
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
- BGN
- BGN
- BGN
- BGN
- BGN
8,050,000.000 BGN
8,050,000.000 BGN
11,476,000.000 BGN
11,476,000.000 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
Other comprehensive income
- BGN
- BGN
87,000.000 BGN
8,000.000 BGN
- BGN
88,000.000 BGN
9,000.000 BGN
59,000.000 BGN
68,000.000 BGN
- BGN
- BGN
- BGN
- BGN
9,000.000 BGN
Comprehensive income
- BGN
- BGN
87,000.000 BGN
8,000.000 BGN
- BGN
7,962,000.000 BGN
8,041,000.000 BGN
11,417,000.000 BGN
11,408,000.000 BGN
- BGN
- BGN
- BGN
- BGN
9,000.000 BGN
Dividends recognised as distributions to owners
10,283,000.000 BGN
10,283,000.000 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.